The Lancet Gastroenterology & Hepatology
First published: 05 January 2018
Elana S Rosenthal, Sarah Kattakuzhy, Shyam Kottilil
Objective: Hepatitis C virus (HCV) is a major cause of liver-related morbidity and mortality worldwide. Ongoing transmission is mostly driven by people who inject drugs (PWID), among whom global HCV antibody prevalence is 52·3%. Although direct-acting antiviral therapy has made this infection curable in most patients, PWID remain largely untreated.